Should You Buy Tesla While It's Below $350?
Tesla (NASDAQ: TSLA) continues to be a volatile business to own. Yes, the shares have soared 463% in the past five years.
Prediction: Ulta Beauty Stock Will Beat the Market. Here's Why.
The market hasn't been too happy with Ulta Beauty (NASDAQ: ULTA) stock recently. It's still reporting higher revenue and ...
3 Reasons to Buy AGNC Investment Stock Like There's No Tomorrow
AGNC Investment (NASDAQ: AGNC) is a real estate investment trust (REIT), but it isn't a landlord, as are most REITs. What ...
Webtoon: Bridging The Gap Between Paperbacks And Digital Storytelling
Webtoon's undervalued stock offers growth potential with a strong market position and diverse revenue streams. Read more on ...
Super Micro Computer (NASDAQ:SMCI) Coverage Initiated by Analysts at Barclays
Equities research analysts at Barclays started coverage on shares of Super Micro Computer (NASDAQ:SMCI – Get Free Report) in a report released on Thursday, MarketBeat reports. The brokerage set an ...
Is Broadcom Inc. (AVGO) the Best Magic Formula Stock for 2025?
We recently published a list of 10 Best Magic Formula Stocks for 2025. In this article, we are going to take a look at where ...
Jim Cramer on Microsoft Corporation (MSFT): ‘Anything That’s That Positive Is Just Wrong. CoPilot, What Is That?’
We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says Bitcoin Created "Froth" In The Market. In ...
Jim Cramer on Tesla, Inc. (TSLA) CEO Elon Musk: ‘There’s A Changeover That He’s Doing On The Autos’
We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says Bitcoin Created "Froth" In The Market. In ...
The Marietta Times3h
Wall Street eases toward the end of its dreary month
Wall Street is easing toward the end of its dreary February, and U.S. stock indexes are drifting following an economic report ...
NewAmsterdam Pharma: Significant Upside Possible In Case Of Approval Of Obicetrapib
NewAmsterdam Pharma's obicetrapib lowers LDL-C in Phase 3 trials, showing promise as a CETP inhibitor. Read more on NAMS ...
Growth Stocks Are Down Bigly. How To Play The 2025 Shake-Up
Heavyweights like Tesla—off 25% YTD—and Palantir—down 20% this month alone—are leading the charge into the red.